Prospective study on mental status in RA patients on tumour necrosis factor vs non-tumour necrosis factor-targeted therapies after achieving treatment target

In RA patients who achieved treatment targets, non-TNF-targeted therapies, particularly IL-6Ri and JAKi, significantly improved anxiety and depression at 1 year compared with TNFi.

Authors

Institutions

Publication Details

Journal
Lara D. Veeken
Published
2025-11-07
DOI
https://doi.org/10.1093/rheumatology/keaf598
Primary Topic
Tryptophan and brain disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prospective study on mental status in RA patients on tumour necrosis factor vs non-tumour necrosis factor-targeted therapies after achieving treatment target

Shuichiro Nakabo, Kosaku Murakami, Koichi Murata, Akio Morinobu et al.
Lara D. Veeken
Tryptophan and brain disorders
article

Prospective study on mental status in RA patients on tumour necrosis factor vs non-tumour necrosis factor-targeted therapies after achieving treatment target

Shuichiro Nakabo, Kosaku Murakami, Koichi Murata, Akio Morinobu, Masao Tanaka, Shuichi Matsuda, Takayuki Fujii, Akira Onishi
article en

Abstract

In RA patients who achieved treatment targets, non-TNF-targeted therapies, particularly IL-6Ri and JAKi, significantly improved anxiety and depression at 1 year compared with TNFi.

Lara D. VeekenVol. 65(2)
Kyoto University (JP)
Openalex Percentile: Top 66%
Tryptophan and brain disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Prospective study on mental status in RA patients on tumour necrosis factor vs non-tumour necrosis factor-targeted therapies after achieving treatment target — Shuichiro Nakabo, Kosaku Murakami, et al. · Lara D. Veeken (2025) | TGRS Research Map | TGRS